Introduction
Quantitative coronary flow reserve (CFR), calculated as the ratio of hyperaemic to resting myocardial blood flow (MBF) estimated using dynamic positron emission tomography (PET) data, has emerged as a powerful marker of the risk for adverse cardiovascular outcomes, including death. [1] [2] [3] However, the extent to which CFR can be used to select appropriate patients with coronary artery disease (CAD) for optimal medical therapy (OMT), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG), remains unclear. Since CFR is an integrated measure of the entire coronary vasculature, reflecting epicardial coronary anatomy, and microvascular dysfunction, 4 both coronary revascularization and medical therapy may increase CFR.
Importantly, several studies have demonstrated that coronary revascularization for CAD is associated with early post-procedural improvements in regional CFR. [5] [6] [7] [8] Conversely, in one single-centre retrospective study, a prognostic difference seen between CABG and PCI was seen only among patients with very low CFR. 3 Importantly, the intermediate and long-term effects of PCI or CABG on global CFR and their effects on outcomes have not been well explored. Therefore, we conducted a prospective, multicentre observational study to determine the effects of OMT, PCI, and CABG on global CFR over 6 months in patients with CAD.
Methods
Between July 2015 and August 2017, patients diagnosed with obstructive CAD, defined as a > _50% diameter stenosis in at least one coronary artery with a reference diameter of > _1.5 mm by visual estimation on invasive coronary angiography, were prospectively identified and recruited at four centres in Japan. Patients with acute coronary syndrome, secondor third-degree atrioventricular block, bronchial asthma, or known or suspected pregnancy were excluded. The study protocol was approved by the ethics committee of each institution and registered with the University Hospital Medical Information Network clinical trials registry (UMIN000018160; http://www.umin.ac.jp/ctr/index.htm). Written informed consent was obtained from all patients in accordance with the Declaration of Helsinki. All patients received guideline-directed OMT 9 for patients with obstructive CAD. Stress myocardial perfusion imaging or invasive assessment of fractional flow reserve was performed at the cardiologist's discretion based on standards of care using previously described methods. 10 Patients with evidence of ischaemia, determined by fractional flow reserve < _0. 8 or reversible perfusion defects on stress myocardial perfusion imaging, were considered for coronary revascularization. Indications for PCI and CABG were determined based on a heart-team approach at each institution, blinded to the results of MBF and CFR assessments.
Patients undergoing PCI were premedicated with dual antiplatelet therapy and treated according to standard practice, primarily with drugeluting stents. Patients undergoing CABG received mainly internal mammary artery grafts with cardiopulmonary bypass (n = 5) or off-pump (n = 21). All CABG patients were given post-operative aspirin indefinitely.
The primary aim of the study was to assess changes in CFR on PET before and 6 months after treatment across treatment groups of OMT alone, PCI, and CABG in the entire cohort. The secondary aim was to identify significant predictors of change in CFR among baseline characteristics and revascularized CAD burden.
Positron emission tomography
All patients were imaged on a whole-body PET/computed tomography (CT) scanner (Gemini TF 64; Philips Healthcare, Cleveland, OH, USA) at Hokkaido University Hospital before and after treatment. MBF was measured at rest and during hyperaemia, as described previously. 11 In brief, patients were instructed to fast for at least 4 h and to refrain from caffeine-and methylxanthine-containing products for at least 24 h. Routine antianginal medications were continued. A prospectively electrocardiographically gated CT scan for coronary artery calcium scoring was performed before the PET scan. After a low-dose CT scan to correct for attenuation and scatter, a 6-min list-mode acquisition was started with concomitant administration of 500 MBq of 15 O-water. After a 10-min interval for tracer decay, an identical scan was repeated during adenosine triphosphate infusion (0.16 mg/kg/min). Adenosine triphosphate was initiated 3 min before the scan and tracer infusion. Heart rate, blood pressure, and 12-lead electrocardiography were recorded at baseline and every minute during pharmacological stress. The emission data were reconstructed using a 3D row-action-maximum-likelihood algorithm into 24 frames (18 Â 10-s and 6 Â 30-s). The estimated radiation exposure per examination was 4.2 mSv, including <0.1 mSv for the scout scan, 1.2 mSv for the CT for coronary artery calcium scoring, 0.7 mSv for the CT for attenuation correction, and 1.1 mSv for each PET scan. PET images were analysed using in-house developed software 11, 12 in a blinded fashion. MBF (mL/g/min) was calculated using a single tissue compartment model with correction for spillover from the myocardium to the blood. CFR was calculated as the ratio of hyperaemic to resting MBF. Global CFR <2.0 was considered reduced, which has been reported as an indicator of high-risk CAD patients. 1, 2 This value is lower than another cut-off point of 2.5 for detecting haemodynamically significant CAD. 13 Regional CFR was assessed in the three main coronary arteries using the American Heart Association 17-segment model to evaluate CFR in the culprit coronary artery. A segment was considered to have ischaemia when the regional hyperaemic MBF was <2.3, which is more diagnostically accurate than using regional CFR <2.5 as the criterion. 13 The extent of myocardial ischaemia was expressed as the percentage of the left ventricle (%LV). In addition, relative flow reserve, defined as the ratio of hyperaemic MBF in a stenotic area (lesion diameter stenosis > _50%) to hyperaemic MBF in a remote area, was also calculated in patients with one-or two-vessel disease to minimize the impact of microvascular dysfunction on perfusion values.
14,15
Angiographic assessment
The SYNTAX score 16 at baseline was calculated in a blinded fashion.
Since the SYNTAX score was developed for patients without CABG, the CABG SYNTAX score 17 was used in patients with CABG. An angiographically successful PCI was defined as <50% residual stenosis of the target lesion after the procedure. The residual SYNTAX score 18 or CABG SYNTAX score after revascularization was calculated from follow-up angiography. If patients did not undergo follow-up angiography, we calculated the residual SYNTAX score from angiography during PCI and the CABG SYNTAX score from the surgical report in conjunction with the baseline angiogram before CABG. The pre-and post-procedure anatomical Leaman score was also calculated as previously described. 19 test the relative contribution of revascularization with CABG on changes in CFR, a linear interaction term (DSYNTAX score Â the CABG group) was added to Model 1 (Model 3). Because of the nonrandomized nature of the study, we used percent change as the dependent variable to minimize the differences in baseline CFR between groups. The pretest likelihood of obstructive CAD was estimated using the Duke clinical risk score, 21 calculated using age, sex, type of angina, history of myocardial infarction, electrocardiographic Q and ST-T wave changes, smoking, hyperlipidaemia, diabetes, and interaction terms (age Â sex, history of myocardial infarction Â electrocardiographic Q wave, age Â smoking, age Â hyperlipidaemia, and sex Â smoking). The assumption of linearity for continuous covariates was evaluated by plotting the residuals against the fitted values. As an exploratory analysis, propensity score matching was used to account for differences in baseline SYNTAX scores between the PCI and CABG groups. Propensity scores were calculated using a logistic regression model including baseline SYNTAX score and the same covariates in the multivariate Model 1 (the pretest likelihood of obstructive CAD, history of PCI or CABG, and left ventricular ejection fraction <50%). A propensity score-matched cohort was generated by 1:1 nearest available matching without replacement using a calliper width equal to 0.2 of the standard deviation of the logit of the propensity score. 22 Propensity score matching was performed using the JMP add-in program (https://www.jmp.com/ja_jp/support/technical-docu ments.html). A two-tailed P-value of <0.05 was considered statistically significant. All statistical analyses were performed using JMP Pro 13.1.0 (SAS Institute Inc., Cary, NC, USA).
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Results
Patient characteristics
We prospectively recruited 82 patients to the study, of whom 30 underwent PCI, and 26 underwent CABG. Of the remaining 26 patients who were treated with OMT alone, 21 had significant comorbidities (e.g. advanced cancer or severely atheromatous aorta) or unsuitable coronary anatomy for coronary revascularization, three preferred medical therapy, and two had fixed perfusion defects in the target area on myocardial perfusion imaging. We excluded seven patients from the final analyses: one patient in the OMT group developed advanced atrioventricular block during adenosine triphosphate infusion at baseline PET and six patients (two in the PCI group and four in the CABG group) withdrew consent during the follow-up period ( Figure 1) . Thus, the final study cohort consisted of 75 patients who completed the second PET.
Baseline clinical characteristics are detailed in Table 1 . The median age of the patients was 70 (63-75) years, 63 patients (84%) were men, and the median pretest likelihood of obstructive CAD was 94% (78-98%). Of these patients, 24 (32%) had one-vessel disease, 22 (29%) had twovessel disease, and 29 (39%) had three-vessel or left main disease. In general, the baseline clinical characteristics were similar between the three groups. The CABG group, however, had higher SYNTAX and Leaman scores and total ischaemic burden, with lower stress MBF and CFR than the OMT and PCI groups, which reflected the non-randomized study design. Figure 2 shows three representative cases.
Baseline CFR was negatively correlated with the SYNTAX (q = -0.40, P < 0.001) and Leaman scores (q = -0.33, P = 0.004) (Figure 3) . Likewise, stress MBF was negatively correlated with the SYNTAX (q = -0.48, P < 0.001) and Leaman scores (q = -0.44, P < 0.001), whereas rest MBF was not significantly correlated with either angiographic score (Supplementary material online, Figure S1 ). Table 2 shows changes in coronary risk factor control and angiographic CAD burden during a median follow-up duration of 6.1 (5.6-6.3) months. Overall, the number of risk factors achieving the targets was high at baseline. The CABG group showed a significant increase in the percentage of patients achieving > _5 risk factor targets, which did not differ significantly between the three groups at follow-up. Medications at follow-up are shown in Supplementary material online, Table S1 .
Changes in coronary risk factor control and angiographic CAD burden
During the follow-up period, none of the patients had adverse cardiac events. The symptoms disappeared after the treatment of CAD in 72 of 75 patients (96%) ( Table 2 ). All 28 patients in the PCI group underwent an angiographically successful PCI. In 17 patients undergoing PCI and scheduled follow-up angiography at a median time of 251 (169-279) days after PCI, 16 had no significant restenosis and one had developed restenosis and underwent repeated PCI after the second PET. In 19 patients undergoing CABG and post-operative angiography at a median time of 9 (8-14) days after CABG, one had early saphenous vein graft
occlusion after CABG and underwent additional PCI in the native coronary artery before the second PET. The SYNTAX and Leaman scores in both the PCI and CABG groups significantly decreased at follow-up ( Table 2) . There was no significant difference in the proportion of patients with low post-revascularization SYNTAX scores (0-8) across the two revascularization groups and the OMT group ( Table 2) .
Changes in CFR and its association with angiographic CAD burden
In the CABG group, stress MBF significantly increased from baseline to follow-up [ 1.22 (0.95-1.48 ) mL/g/min vs. 1 .49 (1.29-1.69) mL/g/min, P < 0.001], resulting in increased CFR [1.67 (1.14-1.96) vs. 1 .98 (1.60-2.39), P < 0.001] (Figure 4A-C) . Conversely, both stress MBF and CFR did not significantly change in the OMT and PCI groups (P > 0.05 for all) ( Figure 4B and C) Figure 4D) . This beneficial effect of PCI on CFR was only observed in patients with baseline CFR <2.0 (P < 0.001 for interaction) ( Figure 4D and 4E). These relationships did not change substantially when patients were stratified by CFR <2.5 and > _2. 5 .
When patients with a baseline SYNTAX score > _23 (n = 23) were analysed, CFR was found to be significantly increased from baseline to follow-up both in the PCI and CABG groups ( Figure 4F) , while there was no significant interaction between time and baseline SYNTAX score in the PCI and CABG groups (P = 0.11 and P = 0.99, respectively). These results did not change substantially when patients were categorised into three SYNTAX subgroups (0-22, 23-32, and > _33) (Supplementary material online, Table S3) .
Among 46 patients with one-or two-vessel disease in this study, 17 (37%) had regional CFR <2.0 in a remote area, reflecting coronary microvascular dysfunction. In nine patients with coronary microvascular dysfunction who underwent PCI (n = 6) or CABG (n = 3), three (one in the PCI group and two in the CABG group) had global CFR <2.0 at follow-up, indicating that their coronary microvascular dysfunction persisted after revascularization. The small number of patients with one-or two-vessel disease prevented a meaningful analysis based on relative flow reserve values. Figure 5 shows changes in CFR and angiographic CAD burden in the PCI and CABG groups. The percent changes in CFR were negatively correlated with DSYNTAX score (q = -0.42, P < 0.001) and DLeaman score (q = -0.44, P < 0.001). The percent changes in CFR and stress MBF were not significantly correlated with coronary artery calcium scores at baseline (P = 0.90 and P = 0.52, respectively).
On a per-vessel basis, the percent change in regional CFR after treatment was significantly higher in coronary territories receiving CABG [21.3% (6.4-53.2%)] than those receiving OMT alone [<50% stenosis: -2.1% (-20.9-18.2%), P < 0.001; and 50-100% stenosis: -1.1% (-21.5- Effects of coronary revascularization on global CFR Figure 2 Eighty-two-year-old man treated with optimal medical therapy alone (A, B). A global CFR of 2.64 at baseline (A) was slightly decreased to 2.57 at follow-up (B). Sixty-six-year-old man receiving PCI (C, D). The polar map of CFR at baseline (C) shows a regional decrease in the anterior to lateral wall. Global CFR was modestly increased from 1.70 to 1.82 
(D) after PCI to the LCX (yellow arrows). Seventy-eight-year-old man receiving CABG (E, F).
A global CFR of 1.23 at baseline (E) was increased to 2.20 (F) after CABG using a RITA graft to the LAD, a left internal thoracic artery graft to the LCX, and a SVG graft from the aorta to the RCA and LCX. All grafts were patent 8 days after the CABG (F (Figure 6 ). There was no significant difference in percent change in regional CFR between coronary territories receiving PCI [19.3% (-11.9-40.7%)] and OMT alone ( Figure 6 ). In addition, the percent change in regional CFR after PCI did not differ between stenoses with fractional flow reserve < _0.8 and those with ischaemia on stress perfusion imaging [-3.7% (-30.9-65.4%) vs. 19 .4% (-11.6-40.0%), P = 0.86].
Predictors of changes in CFR in response to coronary revascularization
The characteristics of patients with increased CFR from baseline to follow-up compared with those without improvement are summarized in Supplementary material online, Table S4 . Independent predictors of changes in CFR between baseline and follow-up PET are summarized in Table 3 . The DSYNTAX score (Model 1) and DLeaman score (Model 2) were independently associated with changes in CFR. Importantly, the extent of improvement in angiographic disease burden, but not the pretest likelihood or left ventricular ejection fraction, was independently associated with changes in CFR. There was no significant interaction between DSYNTAX score and revascularization with CABG (Model 3), indicating that CABG did not amplify the effects of revascularization on CFR.
Propensity score-matched analysis
Supplementary material online, Table S5 shows the clinical characteristics of the matched cohort. The two groups (n = 9 in each group) were well matched at baseline. The CABG group showed a significant increase in CFR [ 1. Although there was no significant interaction between time and the two revascularization groups (P = 0.69), probably due to small sample size, the tendency was consistent with the unmatched cohort.
Discussion
In this prospective multicentre study, we demonstrated that revascularization of obstructive CAD improved CFR and stress MBF and that the degree of improvement was correlated with the degree of reduction of epicardial CAD burden. Importantly, these changes were observed in the context of aggressive risk factor control. Finally, the benefit of PCI for improving CFR was confined to patients with baseline CFR <2.0, whereas CABG was beneficial regardless of baseline CFR. The findings of this study extend previous cross-sectional correlations between CFR and angiographic findings 3 and prognostic studies of CFR [1] [2] [3] to further understand how coronary revascularization impacts this marker. While the nuclear substudy of the COURAGE trial evaluated the impact of revascularization and OMT on single-photon emission CT findings of ischaemia, 23 this modality is relatively insensitive compared to CFR. Our study represents the first multicentre, prospective study to demonstrate that revascularization improves overall myocardial perfusion and coronary vasomotor function as measured by PET CFR and stress MBF. The significant association between reduction in angiographic CAD burden and improvement in CFR has important clinical implications, especially for planning coronary revascularization when multiple stenotic lesions are present. Farooq et al. 18 reported that a greater reduction in the post-procedure residual SYNTAX score was associated with a better outcome. Our findings support this and offer potential mechanistic insights into the underlying pathophysiology of the observation that more complete revascularization is associated with better prognosis. 24 In the ORBITA trial, all patients were pretreated with OMT at randomization, and PCI for single-vessel stenosis did not significantly increase exercise time over a placebo procedure. One reason for this may be the lack of significant increase in global CFR by PCI for singlevessel stenosis. The moderately strong correlation between CFR and angiographic CAD burden in the present study was in line with previous studies using the CAD prognostic index. 3 The Leaman score 19 and CAD prognostic index 3 only take into account the number of diseased vessels and the severity of stenosis, while the SYNTAX score 16 includes not only these factors, but also coronary lesion complexity (e.g. bifurcation lesions, long lesions, heavy calcification). The robustness of these results across angiographic scores supports the generality of the relationship between CFR and the anatomic extent of CAD. Importantly, the residual variability in CFR among patients with obstructive CAD may be explained by diffuse disease and microvascular dysfunction. Importantly, patients with reduced CFR and SYNTAX score <23, for whom microvascular dysfunction may have been a major contributor to CFR reduction, comprised 29% of the cohort (Figure 3 ).
Study limitations
In contrast to other PET studies highlighting the benefits of OMT (including statins, beta-blockers, and nitrates) and risk factor modification on CFR, 25 this study found no effects for OMT on myocardial perfusion.
One reason for this is that a relatively high prevalence of patients already on OMT before inclusion in the study, which reflects evidence-based practice in the modern era. In addition, CFR values were not provided on PET reports to referring cardiologists; therefore, the impact of these metrics on cardiologists' decision making cannot be determined. We did not assess myocardial viability and changes in left ventricular ejection fraction in all the study patients, which may affect the change in CFR after treatment. However, the appropriateness of coronary revascularization was evaluated with conventional myocardial perfusion imaging or invasive fractional flow reserve. Most critically, our findings are subject to selection bias and confounding because of the observational nature of the study, which may introduce bias where the OMT group was reserved for either very mild or very severe CAD, whereas PCI would be performed for less advanced CAD compared with CABG. The results of the subgroup analysis of patients with baseline CFR <2.0, while interesting, may be not robust due to the relatively small sample size. Nonetheless, the change with treatment observed in this small cohort is consistent with the results of the COURAGE nuclear substudy. 23 Due to the multicentre observational nature of the study, there are some Figure 6 Per-vessel relationship between changes in regional CFR and coronary arteries categorized by diameter stenosis and treatment. CABG, coronary artery bypass grafting; OMT, optimal medical therapy; PCI, percutaneous coronary intervention. variations in baseline CFR between groups and in follow-up procedures after coronary revascularization between hospitals. The significance of the coronary haemodynamic findings after revascularization needs to be evaluated in patients with a similar atherosclerotic burden and a predefined procedure of follow-up angiography. Finally, we did not assess the association between changes in CFR after treatment and the patients' outcomes. Further long-term follow-up studies are needed to determine whether an increase in CFR leads to better outcomes in patients with CAD.
Conclusion
Coronary revascularization ameliorated reduced CFR in patients with obstructive CAD. Improvement in CFR was proportionate to reduction in angiographic CAD burden by coronary revascularization. These results suggest that patients with reduced CFR and high-risk CAD may have greater potential to benefit from coronary revascularization.
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Supplementary material is available at Cardiovascular Research online.
